Our Mission

Safer Transfusions, Healthier Patients.
That’s Our Mission.

WATCH VIDEO LEARN MORE

Latest News & Events

Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation

LEXINGTON, Mass., February 02, 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the “Company”), a...

Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB

LEXINGTON, Mass., January 24, 2022, PR NEWSWIRE – Hemanext Inc. today announced that Hemanext...

Hemanext Submits Hemanext ONE System to FDA For U.S. Marketing Authorization

Innovative Blood Processing and Storage System Received CE Mark Certification for Sale in European...

Hemanext successfully closes series a equity funding round, bringing total raised to more than $100 million

Leading Blood Storage Innovator Expanded Series A Round to Accommodate Interest from Noted Private...

INVESTORS

Current and prospective investors access to the investor Portal

COVID 19 Updates

Follow the course of COVID-19 and locate where to donate blood

Educational Symposiums

View educational material and interesting presentations

Our Science

Learn about the journey of red blood cells after donation including degradation that occurs during storage and discover the potential of hypoxic storage to alleviate this problem.

Stored Blood

The average human body stores about 5.6 liters of blood. As it circulates through the body several times each minute, it accomplishes a variety of functions.

Storage Lesion

The existence of the storage lesion process has been well established, and recent scientific work has increased the precision and depth.

Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction¹³, and mortality¹⁴.

Hypoxic Storage

Hemanext is developing a technology to enable the storage of RBC under hypoxic conditions. Removing O2 during storage removes the primary “fuel” for oxidative stress1-11.

Hemanext Research

Learn more about Hemanext and take a closer look at our publications, studies, and posters focused on blood quality and red blood cell characterization.

Worldwide Patent Assets

Accepted Scientific Abstracts

Total Publications

CONNECT WITH HEMANEXT TODAY TO LEARN MORE!

We are happy to answer any questions about the company, our technology, or our research. Fill out the form below and we will connect with you!

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE